ADULT SOLID TUMOR
Clinical trials for ADULT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADULT SOLID TUMOR trials appear
Sign up with your email to follow new studies for ADULT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink bladder tumors before surgery
Disease control OngoingThis study tests whether adding the experimental drug visugromab to standard immunotherapy can help shrink muscle-invasive bladder cancer before surgery. About 31 adults who cannot or choose not to receive cisplatin chemotherapy will receive the combination before having their bl…
Matched conditions: ADULT SOLID TUMOR
Phase: PHASE2 • Sponsor: CatalYm GmbH • Aim: Disease control
Last updated May 17, 2026 05:07 UTC
-
New pill targets cancer's genetic weak spot in 15 tumor types
Disease control OngoingThis study tests a drug called entrectinib in people with advanced solid tumors that have certain gene changes (NTRK, ROS1, or ALK). The drug aims to shrink or control the cancer by blocking these faulty genes. About 534 adults with various cancers, including lung, breast, and br…
Matched conditions: ADULT SOLID TUMOR
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
New hope for hard-to-treat cancers: experimental drug enters human testing
Disease control OngoingThis early-stage study tests a new drug called TT125-802 in about 50 adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check the drug's safety and find the best dose. Researchers will also watch for signs that the drug sh…
Matched conditions: ADULT SOLID TUMOR
Phase: PHASE1 • Sponsor: TOLREMO therapeutics AG • Aim: Disease control
Last updated May 06, 2026 16:02 UTC